Objective: To determine the association of Fecal Calprotectin (f-CP) and M2 Pyruvate Kinase (M2-PK) with intestinal pathogens by means of the gastrointestinal syndromic panel.
Methodology: This retrospective analytic study was conducted in the laboratory department a private hospital in Jakarta from October 2021 to September 2022. The inclusion criteria comprised patients aged ≥18 years with gastrointestinal complaints who had undergone f-CP and M2-PK examinations and gastrointestinal syndromic testing. The exclusion criteria were incomplete data on laboratory examinations, follow-up examinations or treatment evaluations. We used the Mann-Whitney test with p
Key words: Fecal calprotectin, GI-syndromic testing, gastrointestinal infection, M2-PK.
|
Download PDF 
Post
